Bedaquiline, pretomanid and linezolid in multidrug-resistant and pre-extensively drug-resistant tuberculosis in refugees from Ukraine and Somalia in Germany

Eur Respir J. 2024 May 2;63(5):2400303. doi: 10.1183/13993003.00303-2024. Print 2024 May.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents* / therapeutic use
  • Diarylquinolines* / therapeutic use
  • Extensively Drug-Resistant Tuberculosis / drug therapy
  • Female
  • Germany
  • Humans
  • Linezolid* / therapeutic use
  • Male
  • Middle Aged
  • Nitroimidazoles*
  • Oxazoles*
  • Oxazolidinones / therapeutic use
  • Refugees* / statistics & numerical data
  • Somalia
  • Tuberculosis, Multidrug-Resistant* / drug therapy
  • Tuberculosis, Multidrug-Resistant* / epidemiology
  • Ukraine / epidemiology

Substances

  • Linezolid
  • Antitubercular Agents
  • bedaquiline
  • Diarylquinolines
  • OPC-67683
  • Oxazolidinones
  • Nitroimidazoles
  • Oxazoles